Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis

Clinical and Experimental Nephrology

Volumn 15, Issue 4, 2011, Pages 554-559

  Lemes, Helton P ^a,b   Araujo, Salustiano ^b   Nascimento, Daniella ^b   Cunha, Danny ^b   Garcia, Cesar ^b   Queiroz, Vinicius ^b   Ferreira Filho, Sebastiaõ R ^a,b  

^a Rua Paraíba 3055 ^*  (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Chronic renal failure; Furosemide; Residual renal function

Indexed keywords

FUROSEMIDE; SODIUM;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIURESIS; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MALE; PHYSICAL EXAMINATION; RESIDUAL KIDNEY FUNCTION; SODIUM EXCRETION; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS; URINE VOLUME;

ADULT; DIET RECORDS; DIURETICS; FEMALE; FUROSEMIDE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURESIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SODIUM, DIETARY; URINE;

EID: 80054771632     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0427-z     Document Type: Article

References (27)

1. Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis. 2001;38(1):85-90 (Pubitemid 32611763)
2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 2 Suppl 1:S1-266
3. Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf B, Legrain M. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc. 1983;19: 397-403
4. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans. 1991;37(4):598-604
5. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11(3):556-64 (Pubitemid 30115086)
6. Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int. 2001;59(3):1128-33 (Pubitemid 32206877)
7. Chandna SM, Farrington K. Residual renal function: Considerations on its importance and preservation in dialysis patients. Semin Dial. 2004;17(3):196-201 (Pubitemid 38824500)
8. Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, et al. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis. 2007; 49(3):426-31
9. Krediet RT, Douma CE, van Olden RW, Ho-dac-Pannekeet MM, Struijk DG. Augmenting solute clearance in peritoneal dialysis. Kidney Int. 1998;54(6):2218-25 (Pubitemid 28533652)
10. Boesken WH, Kult J. High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure. Clin Nephrol. 1997;48(1):22-8 (Pubitemid 27312082)
11. van Olden RW, van Meyel JJ, Gerlag PG. Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients. Am J Nephrol. 1992;12(5):351-6 (Pubitemid 23039910)
12. Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309(25):1543-6 (Pubitemid 14212836)
13. Katopodis KP, Chasiotis G, Nikolopoulos P, Seferiadis K, Siamopoulos KC. The influence of 24 h urine sampling on the evaluation of renal dysfunction. Nephrol Dial Transplant. 2007; 22(11):3360-2 (Pubitemid 350202571)
14. Rose B. Pathophysiology of renal disease. New York: McGraw- Hill; 1987
15. Caravaca F, Arrobas M, Pizarro JL, Sanchez-Casado E. Uraemic symptoms, nutritional status and renal function in pre-dialysis end-stage renal failure patients. Nephrol Dial Transplant. 2001;16(4):776-82 (Pubitemid 32257975)
16. van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1996;7(5):745-50 (Pubitemid 27466008)
17. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int. 1989;36(4):682-9 (Pubitemid 19239561)
18. Russo D, Memoli B, Andreucci VE. The place of loop diuretics in the treatment of acute and chronic renal failure. Clin Nephrol. 1992;38(Suppl 1):S69-73 (Pubitemid 23092548)
19. Sanjay S, Annigeri RA, Seshadri R, Rao BS, Prakash KC, Mani MK. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease. Nephrology (Carlton). 2008;13(3): 247-50 (Pubitemid 351341457)
20. Schmidt P, Loew D, Dycka J, Kopsa H, Balcke P, Zazgornik J, Deutsch E. Comparison of the effects of muzolimine and furosemide in patients with end stage renal failure on chronic dialysis. Eur J Clin Pharmacol. 1981;20(1):23-6 (Pubitemid 11072737)
21. van Olden RW, van Meyel JJ, Gerlag PG. Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency. Eur J Clin Pharmacol. 1995;47(6):483-8
22. Vasavada N, Saha C, Agarwal R. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. Kidney Int. 2003;64(2):632-40 (Pubitemid 36871936)
23. Van Stone J. The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients. ASAIO J. 1995;41(3):M713-6
24. Hakim RM. Clinical implications of biocompatibility in blood purification membranes. Nephrol Dial Transplant. 2000;15(Suppl 2):16-20
25. Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney Int Suppl. 2000;76:S104-11 (Pubitemid 30612809)
26. Smeby LC, Wideroe TE, Balstad T, Jorstad S. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers. Blood Purif. 1986;4(1-3): 93-101 (Pubitemid 16079373)
27. Brater DC, Anderson SA, Brown-Cartwright D. Response to furosemide in chronic renal insufficiency: Rationale for limited doses. Clin Pharmacol Ther. 1986;40(2):134-9. (Pubitemid 16048873)